<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02962752</url>
  </required_header>
  <id_info>
    <org_study_id>28AI4</org_study_id>
    <nct_id>NCT02962752</nct_id>
  </id_info>
  <brief_title>Pharmacodynamic Profile of 'Blackadder' Blackcurrant Juice Effects Upon the Monoamine Axis in Humans</brief_title>
  <official_title>Pharmacodynamic Profile of 'Blackadder' Blackcurrant Juice Effects Upon the Monoamine Axis in Humans</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Northumbria University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Plant &amp; food Research Ltd</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Northumbria University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The current study uses a double-blind, placebo-controlled, randomised cross- over design to
      assess the pharmacodynamics of the platelet MAO-B inhibition, plasma prolactin levels and
      blood glucose levels after consumption of a single serve of 'Blackadder' blackcurrant juice.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      There is emerging evidence which supports health benefits of consuming blackcurrant fruit,
      including improvements to cognitive performance, modulation of blood flow, regulation of
      blood glucose and inhibition of enzymes underpinning normal cognitive function. Of particular
      relevance is our previous demonstration of inhibition of MAO-A and B after consumption of a
      New Zealand 'Blackadder' blackcurrant juice drink in man.

      In an attempt to establish a &quot;therapeutic window&quot; on which future nutritional interventions
      can be based, the current study will assess the pharmacodynamics of MAO-B inhibition, plasma
      prolactin levels and venous blood glucose profile following consumption of the 'Blackadder'
      blackcurrant juice. The trial will utilise a 500mg dose of the 'Blackadder' juice (equivalent
      to ~100g of fresh fruit) which was shown to have MAO inhibitory effects in our previous
      report and effects will be measured in a cohort of healthy male adults.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2012</start_date>
  <completion_date type="Actual">May 2013</completion_date>
  <primary_completion_date type="Actual">May 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change from baseline Monoamine Oxidase B - Activity</measure>
    <time_frame>15, 30, 45 60, 100, 120, 150, 180 and 240 minutes and 24h post dose.</time_frame>
    <description>Platelet monamine oxidase- B activity as measured by the Invitrogen amplex red assay</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change from baseline peripheral prolactin levels</measure>
    <time_frame>15, 30, 45 60, 100, 120, 150, 180 and 240 minutes and 24h post dose.</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change from baseline postprandial blood glucose</measure>
    <time_frame>15, 30, 45 60, 100, 120, 150, 180 and 240 minutes and 24h post dose.</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">8</enrollment>
  <condition>Monoamine Oxidase Inhibitor Activity</condition>
  <condition>Prolactin Levels</condition>
  <condition>Postprandial Blood Glucose</condition>
  <arm_group>
    <arm_group_label>Blackadder Juice</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Cold pressed Blackadder blackcurrant juice. Standardised at 500mg of polyphenols per 60kg of body weight</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Sugar, flavour and volume matched placebo control drink.</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Blackadder Juice</intervention_name>
    <arm_group_label>Blackadder Juice</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Healthy

          -  Male

          -  Aged 18-35

          -  Non- smoker

          -  No history of metabolic disease

        Exclusion Criteria:

          -  Diagnosis of blood-borne disease

          -  Diagnosed history of any psychiatric disorder

          -  Aged under 18 or over 35 years

          -  BMI above 30 kg/m2 or below 17 kg/m2,

          -  Diagnosis of diabetes or current use of prescription or over-the-counter drugs
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>35 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <verification_date>November 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 7, 2016</study_first_submitted>
  <study_first_submitted_qc>November 9, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 11, 2016</study_first_posted>
  <last_update_submitted>November 9, 2016</last_update_submitted>
  <last_update_submitted_qc>November 9, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 11, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

